NCT02952040View on ClinicalTrials.gov

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Healthy Subjects
Interventions
DRUG

ASP1517

Oral dose

DRUG

Lanthanum carbonate hydrate

Oral dose

Trial Locations (1)

Unknown

Site JP00001, Tokyo

Sponsors

Collaborators (1)

FibroGen
All Listed Sponsors
collaborator

FibroGen

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY